Theravance Biopharma, Inc.
TBPH
$10.69
$0.080.75%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 30.89% | -13.74% | -31.82% | -42.62% | -58.56% |
| Total Receivables | 4.70% | 291.67% | -1.24% | -9.48% | 19.51% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -57.99% | -68.65% | -22.16% | 1.99% | 23.70% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 20.89% | 20.61% | -27.96% | -37.86% | -52.44% |
|
|
|||||
| Total Current Assets | 20.89% | 20.61% | -27.96% | -37.86% | -52.44% |
| Net Property, Plant & Equipment | -21.83% | -21.13% | -20.79% | -16.77% | -14.08% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -21.72% | -22.54% | -1.24% | -1.87% | -2.03% |
| Total Assets | -7.47% | -7.29% | -13.90% | -18.94% | -31.05% |
|
|
|||||
| Total Accounts Payable | 42.82% | 47.11% | -38.60% | 6.69% | -36.69% |
| Total Accrued Expenses | 31.95% | 3.49% | -14.84% | -23.42% | -41.35% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 165.99% | 173.06% | -56.80% | -53.94% | -45.32% |
| Total Finance Division Other Current Liabilities | -9.82% | -9.82% | 26,941.67% | 26,941.67% | 26,941.67% |
| Total Other Current Liabilities | -9.82% | -9.82% | 26,941.67% | 26,941.67% | 26,941.67% |
| Total Current Liabilities | 45.43% | 29.55% | -7.62% | -6.52% | -17.27% |
|
|
|||||
| Total Current Liabilities | 45.43% | 29.55% | -7.62% | -6.52% | -17.27% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -14.81% | -13.55% | -0.81% | -0.19% | 0.18% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 7.74% | 8.51% | 5.21% | 3.57% | 2.95% |
| Total Liabilities | 6.71% | 5.69% | 1.79% | 1.12% | -0.92% |
|
|
|||||
| Common Stock & APIC | 1.72% | 1.68% | -0.99% | -3.51% | -9.69% |
| Retained Earnings | -6.34% | -6.21% | -5.49% | -5.12% | -5.11% |
| Treasury Stock & Other | -- | 110.77% | 122.22% | 92.31% | -180.39% |
| Total Common Equity | -18.98% | -17.58% | -24.57% | -30.87% | -44.71% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -18.98% | -17.58% | -24.57% | -30.87% | -44.71% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -18.98% | -17.58% | -24.57% | -30.87% | -44.71% |
|
|
|||||